NIH 2008 N01 CA |
Early Therapeutics Development with Phase II Emphasis / Sloan-Kettering Institute for Cancer Research |
$417,584 |
NIH 2007 N01 CA |
Early Therapeutics Development with Phase II Emphasis Kelsen, David / |
$1,039,215 |
NIH 2007 N01 CA |
Early Therapeutics Development with Phase II Emphasis / |
$1,039,215 |